-
Posted by
Two Blokes Jun 7 -
Filed in
Stock
-
6 views
Despite a massively successful run as Chief Executive Officer (CEO) of pharma giant Novo Nordisk A/S NYSE: NVO, Lars Fruergaard Jørgensen is on the outs. On May 16, Novo made the announcement that Jørgensen would step down.
